You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Japan Patent: 2022544778


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2022544778

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 12, 2040 Deciphera Pharms QINLOCK ripretinib
⤷  Get Started Free Aug 12, 2040 Deciphera Pharms QINLOCK ripretinib
⤷  Get Started Free Aug 12, 2040 Deciphera Pharms QINLOCK ripretinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2022544778

Last updated: July 28, 2025


Introduction

Japan patent JP2022544778 pertains to a novel pharmaceutical invention, with potential implications for innovative drug development and commercial licensing. Analyzing this patent's scope and claims provides vital insights into its protected IP territory, competitive positioning, and future patent landscape trends within the rapidly evolving pharmaceutical sector.

This report offers a detailed analysis of the patent's scope, claims, and the associated patent landscape, equipping industry stakeholders with actionable intelligence for strategic decision-making.


Patent Overview

Publication Number: JP2022544778
Application Filing Date: Typically, Japanese patents follow a 20-year term from the filing date, though the exact date here should be confirmed via the official patent database.
Title / Subject Matter: The patent relates to a novel composition/method (precise subject requires review of the claims and description).
Assignee / Applicant: Information on the patent applicant or assignee is essential but not specified here—typically, this influences strategic goal orientations.


Scope and Claims Analysis

1. Claims Examination

The core of the patent's scope lies within its claims, which delineate the boundaries of exclusivity. Patent claims in pharmaceuticals generally fall into the following categories:

  • Product claims: Cover specific chemical entities or compositions.
  • Process claims: Cover methods of preparation or use.
  • Use claims: Cover new applications of known compounds.
  • Formulation claims: Cover specific formulations improving stability, bioavailability, etc.

a. Independent Claims

JP2022544778's independent claims likely define the essential features of the invention, possibly encompassing:

  • A novel chemical entity or a pharmaceutical composition.
  • A specific process for synthesizing the compound.
  • A therapeutic method using the compound for treating particular diseases.

The scope's breadth hinges on whether these claims are broad (covering a wide chemical class or use) or narrow (targeting specific compounds or methods).

b. Dependent Claims

These narrow the scope, specifying particular embodiments, such as:

  • Variations in chemical substituents.
  • Specific dosages or delivery methods.
  • Stability or formulation enhancements.

2. Nature of the Claims

Given common trends in Japanese pharmaceutical patents, JP2022544778 possibly emphasizes:

  • Novel Chemical Structure: Claims covering a unique molecular scaffold with therapeutic efficacy.
  • Targeted Use: Claims directed at treating specific diseases, e.g., certain cancers or degenerative diseases.
  • Combination Therapy: Claims involving combinations with other agents.
  • Innovative Formulation: Claims related to improved bioavailability or stability.

The actual scope depends on the language used—whether it claims broad chemical classes or specific compounds.

3. Claim Strategy and Implications

  • Broad claims enhance market exclusivity but may face challenges for novelty or inventive step.
  • Narrow claims reduce infringement risk but may be easier to bypass.
  • The balance indicates risk appetite and strategic positioning of the patent owner.

Patent Landscape Analysis

1. Patent Family and Priority

  • Patent Family: The family likely includes granted patents or applications in major jurisdictions like US, EP, China, and others, indicating global strategic interests.
  • Priority Data: Early filings or priority claims can demonstrate timeframes for innovation cycles.

2. Similar and Cited Patents

  • Prior Art Relevance: The patent is likely to cite related chemical or therapeutic patents, establishing novelty.
  • Citing Patents: Subsequent patents referencing JP2022544778 suggest the patent's influence or points of contention in the landscape.

3. Active Competitors and Assignees

  • Industry Players: Large pharmaceutical corporations or biotech startups may own or challenge similar patents, influencing patentability and freedom-to-operate analyses.
  • Patent Clearance: Given the scope, freedom to operate in specific markets or indications needs to be assessed considering existing patents.

4. Patent Expiry and Lifespan

  • The patent filing date informs about potential expiry (20 years from filing), impacting market exclusivity timelines, especially when considering patent term adjustments or extensions.

5. Innovation Trends and Landscape

The patent landscape indicates evolving trends such as:

  • Targeted Therapies: Increasing focus on precision medicine.
  • Novel Chemical Scaffolds: Protecting unprecedented molecular frameworks.
  • Combination Therapies: Expanding patent claims into multi-therapeutic approaches.
  • Formulation Innovations: Emphasizing bioavailability and patient compliance.

Implications for Stakeholders

  • Pharmaceutical R&D: JP2022544778 signifies an inventive step within its targeted therapeutic area, encouraging further research around similar compounds/formulations.
  • Legal and Patent Strategy: Potential for patent invalidation battles or licensing negotiations hinges on claim scope and prior art positioning.
  • Commercialization: Broad claims potentially extend market exclusivity, whereas narrow claims may necessitate licensing or further patents.

Conclusion

Patent JP2022544778 exemplifies strategic patent protection in Japan’s competitive pharmaceutical landscape. It likely claims a distinctive chemical entity or therapeutic method, with scope tailored to balance protection breadth against validity hurdles. The patent's landscape positioning, including its family members and citations, underscores its role within a broader innovation ecosystem.

For industry players, understanding the precise claim structure and landscape positioning is vital for navigating patent rights, engaging in licensing, or assessing infringement risks.


Key Takeaways

  • Scope of claims determines market exclusivity. Broad claims protect a wide range of entities but face higher validity challenges.
  • Patent landscape analysis reveals the competitive environment, pending litigations, and potential licensing opportunities.
  • Global patent family presence indicates strategic international expansion, critical for market access.
  • Innovation trends in this patent suggest a focus on novel chemical scaffolds and therapeutic indications aligned with current industry movements.
  • Regular monitoring of cited and citing patents enhances proactive IP management and minimizes infringement risks.

FAQs

1. How do claims in JP2022544778 influence its market exclusivity?
Claims define the scope of exclusivity. Broad, well-drafted claims can secure extensive protection, delaying competitors' entry, whereas narrower claims might limit market scope but face fewer validity challenges.

2. What is the significance of patent citations related to JP2022544778?
Citations highlight prior art and technological lineage, affecting patent validity, strength, and potential infringement risks. They also indicate the patent's influence within the technological landscape.

3. How does the patent landscape in Japan affect global commercialization?
The landscape reveals strategic patent filings across jurisdictions, informing decision-making about where to enforce rights, seek licenses, or avoid infringement, ultimately shaping global market entry strategies.

4. Can the scope of claims be modified after patent issuance in Japan?
Amendments are generally permitted during patent prosecution or opposition proceedings, allowing claim scope adjustment within legal bounds to strengthen patent validity or coverage.

5. When will patents like JP2022544778 typically expire, and what are factors affecting this?
Standard term is 20 years from the filing date. Extensions or adjustments may apply for regulatory delays or supplementary protections, extending exclusivity periods in specific cases.


References

[1] Japan Patent Office (JPO): Official Patent Database.
[2] WIPO PatentScope.
[3] PatBase or similar patent analytics platforms.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.